AGIO
AGIOS PHARMACEUTICALS, INC. · Healthcare · Market cap $2.2B
Insiders sold $1.1M net in the last 90 days ·1 seller, 0 buyers· 2 of 2 sales under Rule 10b5-1 plans· latest Form 4 filed Aug 6, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.7M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Aug 6, 2026
Gheuens Sarah
AGIOS PHARMACEUTICALS, INC. (AGIO) has 37 SEC Form 4 filings (91 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Aug 6, 2026.
Inside the rolling window, 8 insiders at AGIOS PHARMACEUTICALS, INC. reported no open-market purchases and 26 open-market sales totaling $4.7M. The most active filer is Chief Medical Officer Gheuens Sarah with 8 filings. Insiders have net sold $3.5M over the trailing 6 months. The most recent open-market filing is a sale of 30,000 shares by Chief Medical Officer Gheuens Sarah, dated Aug 4, 2026, worth $914K.
- Industry:Biotechnology
- CEO:Brian Goff
- Employees:540
- HQ:Cambridge, MA, US
- IPO:2013-07-24
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 30,000 | $914K | Aug 6 | +16.4% | SEC ↗ | |
| Chief Medical Officer | Sale | 4,007 | $151K | Jul 2 | -1.1% | SEC ↗ | |
| Chief Executive Officer | Sale | 19,068 | $662K | Apr 6 | +6.8% | SEC ↗ | |
| Chief Corp Dev & Strategy | Sale | 2,959 | $103K | Apr 6 | +6.8% | SEC ↗ | |
| Chief Medical Officer | Sale | 2,940 | $102K | Apr 6 | +6.8% | SEC ↗ | |
| Chief Legal Officer | Sale | 3,280 | $114K | Apr 6 | +6.8% | SEC ↗ | |
| Chief Financial Officer | Sale | 3,141 | $109K | Apr 6 | +6.8% | SEC ↗ | |
| Chief Commercial Officer | Sale | 3,262 | $113K | Apr 6 | +6.8% | SEC ↗ | |
Viswanadhan KrishnanFirst filing | Chief Corp Dev & Strategy | Sale | 2,959 | $82K | Mar 9 | +30.3% | SEC ↗ |
| Principal Accounting Officer | Sale | 5,272 | $152K | Mar 5 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 5,035 | $146K | Mar 3 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 4,031 | $117K | Mar 3 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 2,868 | $83K | Mar 3 | — | SEC ↗ | |
Washburn Theodore James Jr.First filing | Principal Accounting Officer | Sale | 2,223 | $64K | Mar 3 | — | SEC ↗ |
| Chief Executive Officer | Sale | 18,055 | $523K | Mar 3 | — | SEC ↗ | |
| Chief Commercial Officer | Sale | 2,868 | $83K | Mar 3 | — | SEC ↗ | |
| Chief Commercial Officer | Sale | 2,872 | $78K | Jan 7 | — | SEC ↗ | |
Goff BrianFirst filing | Chief Executive Officer | Sale | 18,703 | $507K | Jan 2 | — | SEC ↗ |
Jones CeciliaFirst filing | Chief Financial Officer | Sale | 2,932 | $79K | Jan 2 | — | SEC ↗ |
Burns James WilliamFirst filing | Chief Legal Officer | Sale | 2,932 | $79K | Jan 2 | — | SEC ↗ |
| Chief Medical Officer | Sale | 2,932 | $79K | Jan 2 | — | SEC ↗ | |
Milanova TsvetaFirst filing | Chief Commercial Officer | Sale | 2,932 | $79K | Jan 2 | — | SEC ↗ |
Scadden DavidFirst filing | Director | Sale | 200 | $9K | Nov 14 | — | SEC ↗ |
| Chief Medical Officer | Sale | 2,454 | $107K | Nov 13 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 200 | $9K | Nov 3 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading AGIO 6 all-time
- DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-08-20
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002026-03-03
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002025-12-11
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002025-04-17
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002025-01-29
- DRep. Josh S. GottheimerPurchase$1,001 - $15,0002024-01-24
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does AGIO have?
AGIOS PHARMACEUTICALS, INC. (AGIO) has 37 SEC Form 4 filings (91 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Aug 6, 2026.
When was the most recent SEC Form 4 filing for AGIO?
The most recent Form 4 filing for AGIO on Tracefour is dated Aug 6, 2026.
Who is the most active insider at AGIO?
The most active SEC Form 4 filer at AGIO in the rolling window is Chief Medical Officer Gheuens Sarah, with 8 filings.
What is the net insider flow at AGIO over the last 6 months?
Over the trailing 180 days, insiders at AGIO have net sold $3.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at AGIO in the current window?
Inside the rolling window, insiders at AGIO bought $0 and sold $4.7M based on SEC Form 4 filings.
Can I get alerts for AGIO insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at AGIOS PHARMACEUTICALS, INC. (AGIO). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
AGIOS PHARMACEUTICALS, INC. is in the Healthcare sector.